Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
BMC Cancer|July 7, 2022
CpG ODN (K3)-toll-like receptor 9 agonist-induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I studyTomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara, et al.Scientific Reports|October 19, 2022
Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patientsKota Iwahori, Takeshi Uenami, Yukihiro Yano, et al.Scientific Reports|September 17, 2013
Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesisToshiyuki Minami, Takashi Kijima, Satoshi Kohmo, et al.Clinical Case Reports|February 28, 2022
COVID-19 in a human T-cell lymphotropic virus type-1 carrierTakatoshi Enomoto, Takayuki Shiroyama, Haruhiko Hirata, et al.Respiratory Medicine|September 11, 2025
Effectiveness of antifibrotic treatment in real-world patients with progressive pulmonary fibrosisTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.RMD Open|January 23, 2023
Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung diseaseTakayuki Niitsu, Kiyoharu Fukushima, Sho Komukai, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2021
IL-33 Induces Sema4A Expression in Dendritic Cells and Exerts Antitumor ImmunityYasuhiko Suga, Izumi Nagatomo, Yuhei Kinehara, et al.Inflammation and Regeneration|December 1, 2022
Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19Takahiro Kawasaki, Yoshito Takeda, Ryuya Edahiro, et al.International Journal of Molecular Sciences|February 13, 2025
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular VesiclesMaiko Naito, Yoshito Takeda, Ryuya Edahiro, et al.The Journal of Allergy and Clinical Immunology. Global|March 6, 2025
Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensateReina Hara, Yoshito Takeda, Takatoshi Enomoto, et al.Pageof 8